Literature DB >> 15877060

Gene therapy: cursed or inching towards credibility?

Malorye A Branca.   

Abstract

Mesh:

Year:  2005        PMID: 15877060     DOI: 10.1038/nbt0505-519

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Gene therapy finds its niche.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

2.  Ark's gene therapy stumbles at the finish line.

Authors:  Peter Mitchell
Journal:  Nat Biotechnol       Date:  2010-03       Impact factor: 54.908

Review 3.  Vector Strategies to Actualize B Cell-Based Gene Therapies.

Authors:  Amanda M Jeske; Paul Boucher; David T Curiel; James E Voss
Journal:  J Immunol       Date:  2021-08-01       Impact factor: 5.426

4.  "Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials.

Authors:  Shelly Benjaminy; Ian Macdonald; Tania Bubela
Journal:  Genet Med       Date:  2013-09-26       Impact factor: 8.822

5.  Construction and characterization of an in-vivo linear covalently closed DNA vector production system.

Authors:  Nafiseh Nafissi; Roderick Slavcev
Journal:  Microb Cell Fact       Date:  2012-12-06       Impact factor: 5.328

6.  Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.

Authors:  Chen Cheng; Na Tang; Jiaxin Li; Shiwei Cao; Tongtong Zhang; Xiaofei Wei; Haoyi Wang
Journal:  J Med Genet       Date:  2018-07-20       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.